Nestlé’s 12Bln Deal to Help Regain Chinese Baby Food Market04-23 15:14 Caijing
Nestle SA has agreed to buy Pfizer’s infant-nutrition business with $11.9 billion, a move could help Nestle regain the Chinese baby food market, Bloomberg reported Monday.
Pfizer on Sunday chose Nestle over Danone SA , which also bid about $11 billion, Bloomberg quoted an anonymous source as saying.
The purchase will help Nestle, already the top seller of infant-nutrition products, regain traction in the Chinese baby- food market where Pfizer has a 7 percent share, according to the report.
Nestle has been losing market share in the country since 2005, when it withdrew two varieties of Neslac milk powder after authorities found they contained excessive iodine.
China's infant nutrition market is a highly competitive one led by Dumex and Mead-Johnson.
Statistics show Nestle had become the 3rd largest infant nutrition
manufacturer in the Chinese market with a 10.58% share, following 16.76%-share
Dumex and 12.06%-share Mead-Johnson by the end of July in 2010.
Editors’ Picks »
- 1China to Introduce Its 401K Tax-Deferred Pension Scheme in 2014
- 2Ten-Year-Old Chinese Girl Abuses Baby, Shocks Nation
- 3China Adds "Debt Issue" in Assessing Local Officials, Shifts away from GDP Obsession
- 4China Makes a Key Step Towards RMB Deposit Rate Liberalization
- 5Wang Jianlin Eyes the China's Growing E-Commerce Market
- 6China’s Online Retail Sales to Top CNY1.8Tln This Year: Commerce Minister
- 7Conference Maps Nation's Path for 2014
- 8The Future of E-Commerce in Asia-Pacific
- 9China’s Asian Import-Export Figures Indicative of Growing Ties
- 10China’s November M2 Up 14.2 pt Y-on-Y